View Older Stories View More Recent Stories

May 25, 2021 09:00AM Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier
May 19, 2021 05:03PM Veracyte (VCYT) Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
May 19, 2021 05:00PM Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
May 18, 2021 05:15PM Veracyte to Present at Upcoming Investor Conferences
May 14, 2021 04:35PM Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
May 14, 2021 12:45PM Veracyte (VCYT) Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
May 14, 2021 12:45PM Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
May 10, 2021 04:10PM Veracyte, Inc. Announces CEO Succession Plan
May 10, 2021 04:05PM Veracyte Announces First Quarter 2021 Financial Results
May 4, 2021 04:45PM Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
Apr 29, 2021 08:30AM Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
Apr 27, 2021 04:48PM Veracyte (VCYT) Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
Apr 27, 2021 04:35PM Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
Apr 20, 2021 01:00PM Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021
Apr 19, 2021 08:30AM Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
Apr 15, 2021 04:07PM Veracyte (VCYT) Announces Retirement of CFO and Preliminary Q1 Results
Apr 15, 2021 04:05PM Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
Apr 14, 2021 08:30AM Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test
Apr 2, 2021 08:15AM Veracyte to Present at 20th Annual Needham Virtual Healthcare Conference
Mar 22, 2021 08:15AM Veracyte (VCYT) Appoints Muna Bhanji to Its Board of Directors
Mar 22, 2021 08:15AM Veracyte Appoints Muna Bhanji to Its Board of Directors
Mar 15, 2021 08:30AM Veracyte Completes Acquisition of Decipher Biosciences
Mar 10, 2021 05:15PM Veracyte Commends New USPSTF Lung Cancer Screening Guidelines
Feb 18, 2021 04:05PM Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference
Feb 17, 2021 04:05PM Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
Feb 11, 2021 04:05PM Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Feb 10, 2021 08:15AM Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021
Feb 3, 2021 07:13AM Veracyte (VCYT) Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
Feb 3, 2021 07:13AM Veracyte (VCYT) to Acquire Decipher Biosciences
Feb 3, 2021 07:05AM Veracyte to Acquire Decipher Biosciences
Feb 3, 2021 07:00AM Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
Jan 6, 2021 02:00PM Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference
Dec 22, 2020 08:15AM Veracyte (VCYT), Bayer Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 22, 2020 08:15AM Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 22, 2020 08:15AM Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 21, 2020 08:15AM Veracyte (VCYT) Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management System
Dec 21, 2020 08:15AM Veracyte Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management System
Dec 16, 2020 12:00PM Veracyte (VCYT) Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests
Dec 16, 2020 12:00PM Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests
Dec 15, 2020 08:16AM Veracyte (VCYT) Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Dec 15, 2020 08:15AM Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Dec 3, 2020 02:30PM Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020
Nov 23, 2020 04:05PM Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 17, 2020 08:35AM Veracyte (VCYT) Announces New General Manager Structure
Nov 17, 2020 08:30AM Veracyte Announces New General Manager Structure to Advance Global Expansion
Nov 5, 2020 03:05AM Prosigna Breast Cancer Assay Now Approved for Reimbursement in Germany
Nov 2, 2020 04:05PM Veracyte Announces Third Quarter 2020 Financial Results
Oct 30, 2020 08:17AM Veracyte (VCYT) Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test’s Genomic Underpinning Drives Prognostic Performance
Oct 30, 2020 08:15AM Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test’s Genomic Underpinning Drives Prognostic Performance
Oct 22, 2020 04:05PM Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier
View More Recent Stories View Older Stories